Medications that are used to treat diseases that affect a relatively small number of people and subsequently generate limited revenue for manufacturers are known as orphan drugs. The government has been offering tax benefits, research grants and market rights to pharmaceutical companies as incentives to develop these orphan drugs, in accordance with the Orphan Drug [...]
